Home603193 • SHA
add
Runben Biotechnology Co Ltd
Previous close
¥38.64
Day range
¥37.30 - ¥39.88
Year range
¥15.80 - ¥39.88
Market cap
15.15B CNY
Avg Volume
3.75M
P/E ratio
49.05
Dividend yield
0.71%
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 240.03M | 44.00% |
Operating expense | 94.17M | 43.43% |
Net income | 44.20M | 24.60% |
Net profit margin | 18.41 | -13.49% |
Earnings per share | — | — |
EBITDA | 49.17M | 53.00% |
Effective tax rate | 12.31% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.39B | 947.09% |
Total assets | 2.30B | 11.45% |
Total liabilities | 176.92M | 63.50% |
Total equity | 2.12B | — |
Shares outstanding | 404.59M | — |
Price to book | 7.36 | — |
Return on assets | 4.90% | — |
Return on capital | 5.26% | — |
Cash Flow
Net change in cash
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 44.20M | 24.60% |
Cash from operations | -15.00M | 47.03% |
Cash from investing | -28.83M | 80.83% |
Cash from financing | -379.77K | 0.00% |
Net change in cash | -44.21M | 75.31% |
Free cash flow | -65.63M | 95.59% |
About
Founded
Dec 30, 2013
Website
Employees
921